Infection Control

Infection Control Market Size is Forecasted to Reach US$ 367 Billion by 2030

According to Precedence Research, during the forecast period of 2022 to 2030, the global infection control market is estimated to develop at a compound annual growth rate (CAGR) of 6.68%. The global infection control market was valued at USD 205 billion in 2021, and it is predicted to exceed USD 367 billion by 2030. The study investigates several elements and their consequences on the growth of the infection control market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1804

This report focuses on infection control market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall infection control market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

Report Scope of the Infection Control Market

Report Coverage Details
Market Size by 2030 USD 367 Billion
Growth Rate from 2022 to 2030 CAGR of 6.68%
Largest Market North America
Fastest Growing Region Asia Pacific
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product & Service, End User, Geography

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of infection control, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of infection control has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the infection control market.

Some of the prominent players in the infection control market include:

  • Getinge AB (Sweden),
  • STERIS plc.
  • Advanced Sterilization Products (US),
  • 3M Company (US),
  • Belimed AG (Switzerland),
  • Cantel Medical Corporation (US),
  • MMM Group
  • MATACHANA GROUP (Spain),
  • Sotera Health LLC (US)

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1804

Segments Covered in the Report

By Product & Service

  • Sterilization Products and Services
    • Sterilization Equipment
      • Heat Sterilization Equipment
        • Moist Heat Sterilizers
        • Dry Heat Sterilizers
      • Low-Temperature Sterilization
        • Hydrogen Peroxide Sterilization
        • Ethylene Oxide Sterilization (ETO)
        • Formaldehyde Sterilization
        • Other Low-Temperature Sterilization
      • Radiation Sterilization
      • Filtration Sterilization
      • Other Equipment
    • Contract Sterilization Services Market
      • ETO Sterilization Services
      • Gamma Sterilization Services
      • E-Beam Sterilization Services
      • Steam Sterilization Services
      • Other Sterilization Services
    • Consumables and Accessories
      • Sterilization Indicators
        • Chemical Indicators
        • Biological Indicators
      • Packaging Accessories
  • Cleaning and Disinfection Products
    • Disinfectants
      • Disinfectants, By Product Type
        • Hand Disinfectants
        • Surface Disinfectants
        • Skin Disinfectants
        • Instrument Disinfectants
      • Disinfectants, By Formulation
        • Disinfectant Wipes
        • Liquid Disinfectants
        • Disinfectant Sprays
      • Disinfectants, By EPA Classification
        • Low-Level Disinfectants
        • Intermediate-Level Disinfectants
        • High-Level Disinfectants
    • Cleaning and Disinfection Equipment
      • Washer-Disinfectors
      • Flusher Disinfectors
      • UV-Ray Disinfectors
      • Ultrasonic Cleaners
      • Other Cleaning and Disinfection Equipment
    • Lubricants and Cleaning Solutions
    • Disinfection and Cleaning Accessories
  • Protective Barriers
    • Medical Nonwovens
      • Surgical Drapes
      • Surgical Gowns
      • Face Masks
    • Covers and Closures
    • Goggles
    • Gloves
  • Endoscope Reprocessing Products
    • Endoscope Reprocessing Consumables
    • Endoscope Reprocessing Equipment
      • Automated Endoscope Re-processors
      • Endoscope Tracking Systems
    • Other Endoscope Reprocessing Products
  • Other Infection Control Products

By End User

  • Hospitals & Clinics
  • Medical Device Companies
  • Pharmaceutical Companies
  • Life Science Industry
  • Food Industry
  • Other

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

  • What can be the best investment choices for venturing into new product and service lines?
  • What value propositions should businesses aim at while making new research and development funding?
  • Which regulations will be most helpful for stakeholders to boost their supply chain network?
  • Which regions might see the demand maturing in certain segments in near future?
  • What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
  • Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
  • Which government regulations might challenge the status of key regional markets?
  • How will the emerging political and economic scenario affect opportunities in key growth areas?
  • What are some of the value-grab opportunities in various segments?
  • What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infection Control Market 

5.1. COVID-19 Landscape: Infection Control Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infection Control Market, By Product & Service

8.1. Infection Control Market, by Product & Service, 2022-2030

8.1.1. Sterilization Products and Services

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Cleaning and Disinfection Products

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Protective Barriers

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Endoscope Reprocessing Products

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Other Infection Control Products

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Infection Control Market, By End User

9.1. Infection Control Market, by End User, 2022-2030

9.1.1. Hospitals & Clinics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Medical Device Companies

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Pharmaceutical Companies

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Life Science Industry

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Food Industry

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Infection Control Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.1.2. Market Revenue and Forecast, by End User (2017-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.1.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.1.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.2.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.2.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.2.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.2.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.2.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.3.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.3.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.3.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.3.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.4.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.4.4.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.4.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.4.6.2. Market Revenue and Forecast, by End User (2017-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.5.2. Market Revenue and Forecast, by End User (2017-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.5.3.2. Market Revenue and Forecast, by End User (2017-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product & Service (2017-2030)

10.5.4.2. Market Revenue and Forecast, by End User (2017-2030)

Chapter 11. Company Profiles

11.1. Getinge AB (Sweden)

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. STERIS plc.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Advanced Sterilization Products (US)

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. 3M Company (US)

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Belimed AG (Switzerland)

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Cantel Medical Corporation (US)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. MMM Group

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. MATACHANA GROUP (Spain)

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Sotera Health LLC (US)

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1804

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *